Session 4B

From Molecule to Market - Harnessing GenAI for End-to-End Drug Development

Abstract:

• Challenges in the drug development process
• Accelerating drug discovery with GenAI
• Enhancing clinical trial design and patient stratification with GenAI
• Optimizing regulatory review and compliance
• Challenges and future perspectives of GenAI in pharma

Speakers: